House Oversight Committee opens probe into FDA's handling of drug shortages
Republican representatives leading the House Committee on Oversight and Accountability today announced an investigation into FDA’s response to critical US drug shortages, including common cancer drugs and antibiotics.
Oversight Committee Chair James Comer (R-KY) and Health Subcommittee Chair Lisa McClain (R-MI) said they’re concerned by the 128 drugs listed by the FDA as being in shortage, including commonly used ones to treat infections, cancer, psychiatric conditions and heart failure.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.